Evidence map›Paper›PMID 40290997›Full record

ArticleACS omega2025

Lipopolysaccharide Detection with Glycan-Specific Lectins-a Nonspecific Binding Approach Applied to Surface Plasmon Resonance.

Mathieu Lamarre, Denis Boudreau

Abstract read
In one paragraph

Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mathieu LamarreDepartment of Chemistry, Pavillon Alexandre-Vachon, 1045, avenue de la Médecine, Université Laval, Quebec City, Quebec G1 V0A6, Canada.
Denis BoudreauDepartment of Chemistry, Pavillon Alexandre-Vachon, 1045, avenue de la Médecine, Université Laval, Quebec City, Quebec G1 V0A6, Canada.ORCID https://orcid.org/0000-0001-5152-2464

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The detection and classification of lipopolysaccharides (LPS), pivotal constituents of Gram-negative bacteria, are fundamental to the progression of biosensing technologies in fields such as healthcare, environmental monitoring, and food safety. This study presents an innovative approach utilizing a panel of glycan-selective lectins in conjunction with surface plasmon resonance (SPR) providing a novel perspective on the evolution of biosensors within the context of the ongoing tension between the highly selective, one-probe-one-target methodology and the broader, resource-intensive approach that integrates complex and costly technological tools into the biosensing discipline. Guided by the principles of lean development, we employed a panel of lectins to construct multiprobe detection profiles, thereby facilitating the precise classification of LPS variants while minimizing both variability and resource expenditure. Advanced machine learning techniques were applied to optimize feature selection and enhance classification accuracy, demonstrating that a minimal set of four lectins sustains exceptional predictive performance. This synergy between traditional affinity techniques and data science enhances assay engineering efficiency, scalability, and integration into routine workflows, supporting frontline pathogen monitoring. This innovative approach holds promise for addressing global health challenges, providing more profound insights into biosensing methodologies, and expanding pathogen screening networks closer to the public and health safety management bodies.

Identifiers

PMID40290997
PMCPMC12019741

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.